← Back to Clinical Trials
Recruiting NCT06325202

Closed Loop and Education for Hypoglycemia Awareness Restoration

Trial Parameters

Condition Diabetes Mellitus, Type 1
Sponsor Milton S. Hershey Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 324
Sex ALL
Min Age 18 Years
Max Age 75 Years
Start Date 2025-10-03
Completion 2029-07-31
Interventions
Omnipod 5 or Medtronic 780GMy HypoCOMPaSS EducationHARPdoc Education

Brief Summary

The purpose of the CLEAR study is to determine the effect on counterregulatory responses (CRR) of intervening (by attempting to strictly avoid hypoglycemia) to improve awareness of hypoglycemic symptoms among adults with type 1 diabetes (T1D) who have impaired awareness of hypoglycemia (IAH). IAH affects 20-25% of adults with T1D, and rises with increasing duration of T1D.

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of type 1 diabetes * Gold Score or Clarke Score ≥ 4 (highly associated with IAH) * Random non-fasting C-peptide \< 200 pmol/L * Diabetes duration ≥ 10 years * HbA1c \< 10.5% * Total Daily Insulin Dose of \< 1 unit/kg * Ability to read and speak English (because validated non-English versions of the cognitive tests and the educational interventions are not available) Exclusion Criteria: * Medical conditions that limit participation in study activities, as determined by the PI (including but not limited to cognitive dysfunction, reduced hearing, reduced vision, cancer under active treatment, untreated angina, organ failure) * Active alcohol or drug abuse (as defined by DSM criteria of either 1) recurrent use of alcohol/drugs resulting in a failure to fulfill major role obligations at work, school, or home, 2) recurrent alcohol/drug use in situations in which it is physically hazardous, or 3) recurrent alcohol or drug-related legal problems) * Soci

Related Trials